1. Background {#sec1}
=============

Globally, several numbers of drugs are brought into the market everyday; however, the safety of medicines remains to be a major concern for various population groups due to inadequate knowledge. According to the World Health Organization (WHO), an adverse drug reaction (ADR) is any deleterious, inadvertent and unwanted reaction to drugs when used for prevention, diagnosis, or treatment purposes at therapeutic doses or for modification of physiological malfunction which precludes accidental or deliberate overdosage or drug maladministration \[[@B1]\]. ADRs can be predictable and dose related, unpredictable and nondose related, both dose and time related, time related (delayed reactions), withdrawal reactions, and unexpected reactions due to treatment failure \[[@B2],[@B3]\].

Modern medicines have substantially changed the diseases treatment schemes that improve the treatment outcomes in many medical conditions. However, adverse reactions to medicines are a common cause of morbidity, hospital admissions, longer hospital stay, disability, and even mortality \[[@B4]\]. Not only they have a major impact on public health but they also reduce patients\' quality of life and impose a significant financial cost in the health care delivery system \[[@B5],[@B6]\].

The history of ADR monitoring has dated back as much as forty years since the milestone of thalidomide disaster that caused phocomelia in thousands of children in many countries \[[@B5],[@B7]\]. Pharmacovigilance is the science and activity related to the detection, assessment, understanding, and prevention of adverse effects or any other possible drug-related problems \[[@B3]\].

Findings from various studies revealed that ADR reporting is linked to the knowledge and attitude of the health care professionals (HCPs). All HCPs in the country need to alert the Ethiopian Food and Drug Administration (EFDA) about suspected adverse drug reactions in order to facilitate immediate and appropriate actions to be taken to prevent or minimize medicine-related injuries for other patients in the future \[[@B2],[@B8]\].

All ADRs ranging from minor to severe reactions should be reported with particular concern to ADRs to new medicines, serious adverse drug reactions, unexpected reactions, and drug interactions which are potentially serious or clinically significant. In addition, uncertainty of the causal relationship between the drug and ADR should not be a reason for not reporting \[[@B2],[@B9]\].

Underreporting of ADRs by HCPs to the concerned body has long been a big challenge in Ethiopia. Search of literature with regard to knowledge, attitude, and practice (KAP) of HCPs towards ADR reporting in the study areas yielded no results; hence, it is found important to conduct this study to investigate the gaps on KAP of HCPs about ADR reporting and identify factors attributable for inadequate knowledge.

2. Methods {#sec2}
==========

2.1. Study Area, Design, and Period {#sec2.1}
-----------------------------------

A hospital-based quantitative cross-sectional study design was used among HCPs (nurses, medical doctors, pharmacy professionals, midwives, and health officers) working at Kemisse General Hospital (KGH) and Ataye Primary Hospital (APH), Northeast Ethiopia. KGH is located in Northeast Ethiopia, Oromia Special Zone, Amhara National Regional State, 331 km away from north of Addis Ababa. KGH is the only general hospital in a zone that serves 1.2 million populations. APH is located in the North Shewa zone, Amhara National Regional State, 300 km away from north of Addis Ababa and 31 km away from south of Kemisse. The study was conducted from May 1 to May 30, 2019.

2.2. Study Population {#sec2.2}
---------------------

The study population included all physicians, pharmacy professionals, health officers and nurses, midwives who were working in selected hospitals during the study period.

2.3. Variables {#sec2.3}
--------------

Dependent variablesOverall knowledge of HCPs about ADR reportingOverall attitude of HCPs towards ADR reportingIndependent variablesAge, sex, profession, level of education, years of experience, and attending training on ADR reporting and type of hospital (primary or general)

2.4. Sampling Technique and Sample Size Determination {#sec2.4}
-----------------------------------------------------

Convenience sampling technique was used to select all HCPs who have frequent exposure to the ADR.

2.5. Data Collection Tool and Data Collection Process {#sec2.5}
-----------------------------------------------------

A structured self-administered questionnaire was used. The questionnaire was developed by modifying the tools from other similar studies and the EFDA guidelines \[[@B2], [@B6], [@B10]--[@B14]\]. Information about the sociodemographic characteristics of respondents and detailed questions used to assess knowledge, attitude, and practices of respondents was included. Prior to commencing the study, the questionnaire with attached written consent form was distributed to HCPs. Participation of the respondents was entirely voluntary.

2.6. Data Entry, Management, and Statistical Analysis {#sec2.6}
-----------------------------------------------------

Data were entered into Epi info version 3.5.3, cleaned, and then exported to Statistical Package for the Social Sciences (SPSS) version 20 statistical software for analysis. Both descriptive and analytical statistical tests were done. Bivariate and multivariate binary logistic regression analysis was performed to find association between different independent variables and participants\' overall knowledge and attitude towards ADR reporting. A *p* value \<0.05 was considered as statistically significant association.

In this survey, knowledge of HCPs about ADR reporting was assessed with twelve questions. Each correct response had a score of 1, and each wrong response had a score of 0. Thus, the total score varies from 0 to 12 points ([Table 1](#tab1){ref-type="table"}). The overall level of knowledge was categorized by using the mean score. Participants who score more than or equal to the mean score were classified as having adequate knowledge, and scores below the mean were classified as having an inadequate knowledge. The participants\' attitude was evaluated by using thirteen questions rated on a three-point Likert scale such as agree, neutral, and disagree. A response of "agree" was given a score of 3, "neutral" a score of 2, and "disagree" a score of 1, and a score more than or equal to 75% was indicative of a favorable attitude, and a score below 75% would be indicative of unfavorable attitude towards ADR reporting. HCPs\' practice was assessed by identifying whether they documented and reported ADRs or not.

2.7. Data Quality Control Measures {#sec2.7}
----------------------------------

After the data collection format was prepared, pretest of the tool was done on 10 HCPs working at Dessie Referral Hospital for any necessary amendments to check its suitability for the actual data collection. And, the data were cleared and checked everyday for completeness and consistency before data processing and analysis.  Adequate knowledge on ADR reporting: those who had a score of more than or equal to a mean score out of 12 questions used to assess knowledge of the respondents  Favorable attitude towards ADR reporting: those who had a score of more than or equal to 75% response (score ≥ 29.25 on 3-point Likert scale) of the total 13 questions used to assess attitudes of the respondents  Good practice: those who documented and reported the encountered ADRs  Inadequate knowledge: those who had less than 6 correct response of the total 12 questions  Poor practice: those who did not document and report the encountered ADRs  Unfavorable attitude: those who had less than 75% response (score \< 29.25) of the total 13 questions

3. Results {#sec3}
==========

3.1. Sociodemographic Characteristics {#sec3.1}
-------------------------------------

The study was conducted in KGH and APH among 114 HCPs to assess KAP towards ADR reporting. From 120 self-administered questionnaires distributed, 114 were adequately filled and returned within the stipulated time frame giving 95% response rate. Among 114 respondents, 72 (63.2%) and 42 (36.8%) were males and females, respectively. The mean age of respondents was 27.54 (±3.88), and most of them (81, 71.05%) were in the age range of 25--34 years. Most of the respondents (49, 43. 0%) were nurses followed by physicians (26, 22.8%), pharmacy professionals (17, 14.9%), health officers (12, 10.5%), and midwives (10, 8.8%). Most respondents (95 (83.3%)) did not take training on ADR reporting ([Table 2](#tab2){ref-type="table"}).

3.2. Knowledge and General Awareness of HCPs on ADR Reporting {#sec3.2}
-------------------------------------------------------------

Twelve different questions were used to assess knowledge of HCPs on ADR reporting. 100 (87.7%) respondents knew that all drugs available in the market are not safe, and 76 (66.7%) were able to differentiate ADR from overdose toxicities. Only 23 (20.2%) respondents knew the term pharmacovigilance and understood its function. Likewise, 24 (21.1%) and 26 (22.8%) respondents knew the availability of national reporting system and ADR reporting form in Ethiopia, respectively. 35 (30.7%) respondents knew the responsible body that monitor ADRs in Ethiopia. Less than half of respondents (55 (48.2%)) knew that ADR reporting is a professional obligation. 25 (21.9%) respondents replied that the possibility of an ADR should be the first differential diagnosis at all times in patients taking medicines. Moreover, significant proportion of the respondents (93 (81.6%) and 52 (45.6%)) replied that ADRs should be reported only when they are serious and life-threatening and severe and cause disability, respectively ([Table 1](#tab1){ref-type="table"}).

When the general awareness of respondents was assessed, the study has found that more than half of the respondents (64 (56.1%)) were using National Drug Formulary and Standard Treatment Guideline (STG) followed by standard text books (53 (46.5%)) as the main sources of information about ADR. 37 (32.5%) and 32 (28.1%) of the respondents responded that ADRs should be reported to EFDA and Drug and Therapeutic Committee (DTC) of the respective health facility, respectively. Prescribing error, dispensing error, life style of the patient, overdose, and nonadherence are the possible factors that predispose a patient to ADR in 92 (80.7%), 87 (76.5%), 86 (75.4%), 79 (69.3%), and 55 (48.2%) respondents, respectively ([Table 3](#tab3){ref-type="table"}).

3.3. Attitude of HCPs towards ADR Reporting {#sec3.3}
-------------------------------------------

Regarding the attitude of HCPs towards ADR reporting, 100 (87.7%) respondents agreed that ADR reporting should be part of their duty and 87 (76.3%) supported that ADR reporting should be compulsory and 84 (73.7%) agreed that one report of ADR makes a difference. Besides, most respondents 108 (94.7%) and 101 (88.6%) agreed that reporting ADR is important for the public and improves quality of patient care, respectively. 88 (77.2%) health professionals agreed that ADRs should be reported spontaneously at a regular base with 87 (76.3%) emphasizing that there should be certainty for ADRs related to the drug before reporting. Approximately half of respondents (60 (52.6%)) worried about legal problems while ADR reporting ([Table 4](#tab4){ref-type="table"}).

3.4. Practice of HCPs regarding Identification, Recording, and Reporting of ADRs {#sec3.4}
--------------------------------------------------------------------------------

The present study has found that only a small number of respondents (34 (29.82%)) encountered at least one patient with ADR in the past 12 months of their clinical practice, out of which 24 (70.59%) and 17 (50%) respondents recorded and reported ADRs, respectively. From those who have reported ADRs, 8 (47.06%) respondents reported to hospital and pharmacy department and 5 (29.41%) respondents to EFDA. Although about half of the respondents (59 (51.8%)) preferred yellow card for ADR reporting, most of them did not use it regularly due to unavailability of the form. In addition, 44 (38.60%) HCPs have not been usually given proper advice to their patients on possible adverse effects of drugs they prescribed, dispensed, or administered ([Table 5](#tab5){ref-type="table"}).

3.5. HCPs\' Reasons for Not Reporting ADRs and Suggested Strategies to Improve ADR Reporting {#sec3.5}
--------------------------------------------------------------------------------------------

On a 5-point Likert scale evaluation of the reasons for not reporting ADRs, respondents agreed that lack of feedback (67 (58.8%)), reporting forms are not available when needed (53 (46.4%)), not knowing where to report (53 (46.4%)), not knowing how to fill and report the report form (47 (41.2%)), other colleagues are not reporting ADR cases (43 (37.7%)), and uncertain that causal association between the drug and ADR (41 (35.9%)) were the leading discouraging factors contributing to underreporting in hospitals ([Table 6](#tab6){ref-type="table"}).

The most common strategic approaches suggested by the respondents to foster ADR reporting were availability of ADR information sheets at OPD (92 (80.7%)), encouraging all health professionals to report (86 (75.4%)), training to report ADR (83 (72.8%)), encouraging patients to report (76 (66.7%)), drug information center assistance (76 (66.7%)), and easy accessibility to ADR forms (68 (59.6%)) ([Figure 1](#fig1){ref-type="fig"}).

3.6. Factors Associated with HCPs\' Knowledge of ADR Reporting {#sec3.6}
--------------------------------------------------------------

Bivariate logistic regression analysis was run to identify any association between different independent variables and knowledge of HCPs on ADR reporting. Accordingly, attending training on ADR reporting and type of profession were found to have statistically significant association with knowledge. Participants who had not taken training on ADR reporting were 0.722 times (72.2%) less likely to have adequate knowledge compared with participants who had taken training on ADR reporting \[COR = 0.278, 95% CI = 0.099--0.779\]. Also, nurses, health officers, physicians, and midwives were 94.2% \[COR = 0.058, 95% CI = 0.015--0.224\], 91.7% \[COR = 0.083, 95% CI = 0.013--0.526\], 90.1% \[COR = 0.099, 95% CI = 0.024--0.414)\], and 82.1% \[COR = 0.179, 95% CI = 0.032--0.985\] times less likely to have adequate knowledge on ADR reporting compared with pharmacy professionals, respectively. Multivariable binary logistic analysis was also run to look into associations controlling any potential confounders. Accordingly, only the type of profession was found to have statistically significant association with knowledge. Nurses, health officers, and physicians were 93.1% \[AOR = 0.069, 95% CI = 0.018--0.275\], 90% \[AOR = 0.10, 95% CI = 0.015--0.647\], and 86% \[AOR = 0.14, 95% CI = 0.03--0.64\] times less likely to have adequate knowledge on ADR reporting compared with pharmacy professionals, respectively. However, none of these variables were found to associate with attitude of HCPs towards ADR reporting ([Table 7](#tab7){ref-type="table"}).

4. Discussion {#sec4}
=============

Since ADRs are an important cause of morbidity and mortality and increased health care costs, all HCPs should be alert and keen towards any unexpected or suspected reactions occurring in patients taking medicines, assessing, managing, and reporting the encountered adverse events, which are an integral part of the pharmaceutical care process \[[@B2],[@B8],[@B15]\].

In the present study, the knowledge of HCPs on ADR reporting was low with only 24.56% of the HCPs having adequate knowledge ([Figure 2](#fig2){ref-type="fig"}). This result was consistent with similar studies; 21.1% respondents in Tikur Anbessa Specialized Hospital (TASH), Addis Ababa \[[@B14]\], 23.17% in Southwest Ethiopia \[[@B16]\], 33.33% in Northeast Ethiopia \[[@B17]\], and 34.2% in Amhara region, Ethiopia \[[@B12]\], had adequate knowledge about ADR reporting. But this finding was lower than other similar studies; 39.4% of HCPs in Nepal \[[@B18]\], 39.6% in Saudi Arabia \[[@B19]\], 48.2% in Nekemte town, Ethiopia \[[@B6]\], 53% in Gondar town, Ethiopia \[[@B10]\], and 77% in Philippines \[[@B20]\], had adequate knowledge.

In the current study, 66.67% respondents said ADR is different from overdose toxicities or side effects. This figure is higher than a study conducted in Gondar town (64.7%) \[[@B10]\] and Addis Ababa (53. 5%) \[[@B14]\]. However, this result is lower than a result reported by pharmacy professionals in Addis Ababa (85.2%) \[[@B21]\]. But the WHO recommended that the term side effect refers to minor effects related to the pharmacological properties of the drug \[[@B7], [@B22]\]. In addition, 20.18% of the respondents knew the term pharmacovigilance and its activities which are comparable with a study done in the Jimma zone (19.5%) \[[@B16]\]. Moreover, the present study indicated that a small number of respondents knew the availability of national reporting system (22.81%) and ADR reporting form (21.05%), which is lower than 40.4% in a study done in Lagos, Nigeria \[[@B23],[@B24]\], 49.02% in Gondar \[[@B10]\], and 63.4% at TASH, Addis Ababa \[[@B14]\].

Besides, 58.77% of respondents were aware that all HCPs are responsible and an obligation to report ADRs to the concerned body in contrast to 81.1% in a study conducted in the Amhara region \[[@B12]\]. Moreover, 21.93% of the HCPs said that the possibility of ADR is the first differential diagnosis at all times in patients taking medicines opposed to a report by EFDA, the regulatory agency of Ethiopia \[[@B2]\]. One possible explanation for insufficient knowledge of respondents in this study was that only 19 (16.67%) respondents had taken training on ADRs and their reporting. Hence, creating awareness, providing training, and upgrade knowledge of HCPs about how ADRs are the priority causes of morbidity and mortality and the essence of ADR reporting to the public is essential.

Significant proportion of the respondents (81.58%) replied that ADRs should be reported only when they are serious and life-threatening, while a few respondents (21.05%) were aware that mild to moderate unexpected, certain, and suspected reactions need to be reported. In contrast, a study done in one of the tertiary centers in Northern Nigeria showed that a majority (\>70%) of the respondents were aware that suspected, serious, and certain reactions should be reported \[[@B25]\] and 48.6% in a study conducted in Amhara \[[@B12]\]. ADRs are the most ignored but yet constitute the major drug therapy problems and the most important ones to cause major impact on public health, reducing patients\' quality of life and a considerable financial burden, and hence, their reporting deemed to be very essential.

Despite the inadequate knowledge of the HCPs, the majority 73.68% had favorable attitude towards ADR reporting ([Figure 3](#fig3){ref-type="fig"}), which is higher than reports from other studies; 26.9% in Malaysia \[[@B26]\], 42.1% in Nekemte town, West Ethiopia \[[@B6]\], 52.1% in TASH, Addis Ababa \[[@B14]\], and 66.3% in Nepal \[[@B18]\]. But the present finding is lower than other reports; 82.2% in south India \[[@B27]\], 86% in Gondar town, North Ethiopia \[[@B10]\], 86% in Boru Meda hospital \[[@B17]\], and 90% in other parts of India \[[@B28]\] had positive attitude about ADR reporting. This study showed that 87.7% of respondents agreed that ADR reporting should be part of their duty, which is in line with the findings from similar studies in Addis Ababa, 84% \[[@B14]\], Gondar, 84.3% \[[@B10]\], but higher than a study in Jimma, 57.31% \[[@B16]\]. In addition, 76.3% respondents agreed that affirmation of ADRs related to the drug is necessary before reporting in contrast to 83.3% respondents in a study conducted at Gondar \[[@B10]\]. This perceived obligation to establish causal relation and feeling of legal problems might be one reason for the low reporting rates. Considerable number of respondents (73.7%) agreed that ADR reporting is time-consuming activity and about half (52.6%) of HCPs believed that ADR reporting creates additional workload. This perception of the respondents may substantially affect their motivation of ADR reporting in their clinical practice.

Looking at the practice of HCPs about ADR reporting, the present study revealed that 29.82% ([Figure 4](#fig4){ref-type="fig"}) in contrast with 38% in TASH, Addis Ababa \[[@B14]\], 55.9% in Gondar \[[@B10]\], 65% in Turkish \[[@B29]\], and 81% in Northern Nigeria \[[@B25]\] encountered patients with ADR in their clinical practice in the past 12 months. Among those HCPs who encountered ADRs, 50% claimed that they have reported the ADR despite only 29.41% reported to appropriate body EFDA. Underreporting of ADRs by HCPs remains to be a challenge in Ethiopia. Not only the health professionals working in hospitals but also the medicine regulatory agencies have to work jointly to monitor drug safety issues and maintain a balance between medicines\' benefits and risks.

The major reasons for not reporting of ADRs were lack of feedback; reporting forms are not available when needed, not knowing where to report, not knowing how to fill and report ADR, uncertain of the causal association between the drug and ADR, and insufficient clinical knowledge, among others. Regular sensitization programs such as continued education and workshops and trainings, timely availability of ADR forms and ADR information sheets, feedback, and communication with the concerned bodies (e.g., EFDA) and encouraging all health professionals and patients to report suspected ADRs were some of the strategies forwarded by the respondents to foster ADR reporting ([Figure 1](#fig1){ref-type="fig"}). These training programs and continuous feedback clear all misconceptions associated with the ADR reporting as the previous reports have shown significant improvement in knowledge, attitude, and practice of health care workers about ADR after intervention \[[@B30]--[@B32]\].

Regarding the factors that affect knowledge of ADR reporting, nurses, health officers, and physicians were 93.1% \[AOR = 0.069, 95% Cl (0.018--0.275)\], 90% \[AOR = 0.10, 95% Cl (0.015--0.647)\], and 86% \[AOR = 0.14, 95% Cl (0.03--0.64)\] times less likely to have adequate knowledge compared with pharmacy professionals, respectively. Similarly, in one study, nurses (*p*=0.001) and health officers (*p*=0.019) had an inadequate knowledge compared to pharmacy professionals \[[@B10]\]. In contrary, a similar study done in the Philippines showed that 86% nurses and 72% of physicians had a good knowledge about ADR reporting and 61% of pharmacists had an adequate knowledge \[[@B20]\].

Conduction of this study was not without limitation. One of the limitations was that we did not include all HCPs working in a hospital, and only those having frequent exposure to drugs and patients were selected. The sample size was small. However, the inclusion of different HCPs does make it valuable. As the study used self-administered questionnaire, recall and personal bias may have affected the data obtained. Above all, it is a simple assessment of KAP in specific hospitals that does not assess multisectors and sort out problems in the area of pharmacovigilance, but without denying that the findings from this study are inputs for further researchers.

From total 114 HCPs, 28 (24.56%) had adequate knowledge, among which pharmacy personnel accounted the majority 42.86%. On the contrary, 86 (75.44%) had inadequate knowledge, of which half of them were nurses followed by physicians (24.42%).

From total 114 HCPs, 84 (73.68%) had favorable attitude about ADR reporting, in which more than half of them were nurses (60%) followed by health officers (16.67%). On the contrary, 30 (26.32%) had unfavorable attitude.

5. Conclusion {#sec5}
=============

The present study identified that HCPs working in KGH and APH had inadequate knowledge on ADR reporting and poor documentation and ADR reporting practice which contributed to underreporting in hospitals to EFDA despite the majority HCPs had favorable attitude towards ADR reporting. Hence, taking into account HCPs\' suggestions and the study findings, the present study strongly underscore that creating awareness and improving the knowledge of all HCPs through regular sensitization programs, trainings, and timely feedback is a very crucial strategy to enhance spontaneous ADRs reporting in health facilities to the concerned body, which ultimately impacts the provision of quality patient care.
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![Overall practice of HCPs on ADR reporting in selected public hospitals, Northeast Ethiopia, May 2019. Out of 114 HCPs, only 17 (14.91%) participants had documented and reported encountered ADRs. However, 97 (85.09%) participants did not encounter, document, and/or report ADRs.](BMRI2019-8690546.004){#fig4}

###### 

Health care providers\' knowledge of ADR in selected public hospitals, Northeast Ethiopia, May 2019.

  Questions                                                                                          Category                       Frequency   Percentage
  -------------------------------------------------------------------------------------------------- ------------------------------ ----------- ------------
  Know that all drugs in the market are not safe                                                     Yes                            100         87.72
  No                                                                                                 14                             12.28       
                                                                                                                                                
  Know ADR is different from overdose toxicities/side effects                                        Yes                            76          66.67
  No                                                                                                 38                             33.33       
                                                                                                                                                
  Know the term pharmacovigilance                                                                    Yes                            23          20.18
  No                                                                                                 91                             79.82       
                                                                                                                                                
  Write the definition of pharmacovigilance^*∗*^                                                     Yes                            10          8.77
  No                                                                                                 104                            91.23       
                                                                                                                                                
  Know national ADR reporting system                                                                 Yes                            24          21.05
  No                                                                                                 90                             78.95       
                                                                                                                                                
  Know availability of ADR reporting forms                                                           Yes                            26          22.81
  No                                                                                                 88                             77.19       
                                                                                                                                                
  Know how to report                                                                                 Yes                            23          20.18
  No                                                                                                 91                             79.82       
                                                                                                                                                
  Know the responsible body that monitors ADR in Ethiopia                                            Yes                            35          30.70
  No                                                                                                 79                             69.30       
                                                                                                                                                
  Know ADR reporting is a professional obligation                                                    Yes                            55          48.25
  No                                                                                                 59                             51.75       
                                                                                                                                                
  The possibility of an ADR should be the first differential diagnosis at all times                  Yes                            25          21.93
  No                                                                                                 89                             78.07       
                                                                                                                                                
  Who is the responsible professional to report ADR in hospitals? (yes answers are only indicated)   Medical doctors                84          73.68
  Health officers                                                                                    77                             67.54       
  Midwives                                                                                           68                             59.65       
  Nurses                                                                                             75                             65.79       
  Pharmacy personnel                                                                                 98                             85.96       
  All                                                                                                67                             58.77       
                                                                                                                                                
  When should ADRs be reported? (yes answers are only indicated)                                     Serious and life-threatening   93          81.58
  Severe and cause disability                                                                        52                             45.61       
  Mild and cause less inconvenience                                                                  24                             21.05       
                                                                                                                                                
  What kinds of ADRs need to be reported? (yes answers are only indicated)                           Suspected reactions            50          43.86
  Certain reactions                                                                                  55                             48.25       
  Serious reaction, e.g., SJS                                                                        70                             61.40       
  Slight reaction, e.g., nausea                                                                      11                             9.65        
  Reaction to all drugs                                                                              31                             27.19       
  Reaction to new drugs                                                                              42                             36.84       
  Known reactions                                                                                    20                             17.54       
  Unexpected reactions                                                                               49                             42.98       
  Drug interactions                                                                                  33                             28.95       
  Teratogenic phenomenon                                                                             48                             42.11       

^*∗*^For this item, the correct response was considered when the study participant wrote not only the precise definition but also the general concept of pharmacovigilance. Do not know and unrelated responses were considered as incorrect.

###### 

Sociodemographic characteristics of HCPs in selected public hospitals, Northeast Ethiopia, May 2019.

  Variables                      Category    Frequency (*n* = 114)   Percentage
  ------------------------------ ----------- ----------------------- ------------
  Age                            \<25        25                      21.93
  25--34                         81          71.05                   
  ≥35                            8           7.02                    
                                                                     
  Sex                            Male        72                      63.16
  Female                         42          36.84                   
                                                                     
  Profession                     Physician   26                      22.81
  Pharmacy personnel             17          14.91                   
  Nurse                          49          42.98                   
  Health officer                 12          10.53                   
  Midwifery                      10          8.77                    
                                                                     
  Level of education             Diploma     20                      17.54
  BSC degree                     88          77.19                   
  MSc/MPH                        6           5.26                    
                                                                     
  Years of clinical experience   \<3         56                      49.12
  ≥3                             59          51.75                   
                                                                     
  Trained on ADR reporting       Yes         19                      16.67
  No                             95          83.33                   

###### 

General awareness of HCPs about ADR reporting in selected public hospitals, Northeast Ethiopia, May 2019.

  Questions                                                                                                     Frequency   Percentage
  ------------------------------------------------------------------------------------------------------------- ----------- ------------
  *To whom do you think that ADRs should be reported?*                                                                       
  Manufacturers                                                                                                 17          14.91
  MOH                                                                                                           32          28.07
  EPA                                                                                                           22          19.30
  EFDA^*∗*^                                                                                                     37          32.46
  DTC of the respective health facility                                                                         19          16.67
  Pharmacy department                                                                                           23          20.18
  *Who is primarily responsible to remind and follow-up patients about side effects of drugs they are given?*                
  Physicians                                                                                                    74          64.91
  Pharmacists                                                                                                   94          82.46
  Nurses                                                                                                        80          70.18
  Midwifery                                                                                                     66          57.89
  Health officers                                                                                               72          63.16
  *What is your source of information about ADR?*                                                                            
  National drug formulary and STG                                                                               64          56.14
  Standard text books                                                                                           53          46.49
  Drug sales man                                                                                                14          12.28
  Notes from the training                                                                                       19          16.67
  Search engines (Internet)                                                                                     23          20.18
  Journal articles                                                                                              14          12.28
  Package inserts                                                                                               24          21.05
  Advertisement brochures/leaflets                                                                              20          17.54
  Direct call to a pharmaceutical company                                                                       11          9.65
  Pharmaceutical company representative                                                                         16          14.04
  *What possible factor(s) predispose a patient to ADR?*                                                                     
  Dispensing error                                                                                              87          76.32
  Prescription error                                                                                            92          80.70
  Overdose                                                                                                      86          75.44
  Life style of the patient                                                                                     79          69.30
  Nonadherence                                                                                                  55          48.25

^*∗*^Correct knowledge. MOH: Ministry of Health; EFDA: Food, Medicine, Health Care Administrative and Control Authority; STG: Standard Treatment Guideline; EPA: Ethiopian Pharmaceutical Association; DTC: Drug Therapeutic Committee.

###### 

Attitudes towards ADR reporting among HCPs in selected public hospitals, Northeast Ethiopia, May 2019 (*N* = 114).

  Questions                                                                            Agree         Disagree     Neutral
  ------------------------------------------------------------------------------------ ------------- ------------ ------------
  Do you feel that ADR reporting can benefit the public health?                        108 (94.74)   6 (5.26)     0
  Do you feel that ADR reporting improves quality of patient care?                     101 (88.60)   10 (8.77)    3 (2.63)
  Do you feel that one report can make a difference?                                   84 (73.68)    18 (15.79)   12 (10.53)
  Do you feel that ADR reporting is part of duty of HCPs?                              100 (87.72)   12 (10.53)   2 (1.75)
  Do you feel that reporting ADR should be compulsory?                                 87 (76.32)    17 (14.91)   10 (8.77)
  Do you feel that only ADR that cause persistent disability should be reported?       48 (42.11)    64 (56.14)   2 (1.75)
  Do you feel that ADR reporting is time-consuming activity with no outcome?           27 (23.68)    84 (73.68)   3 (2.63)
  Do you feel that ADR reporting creates additional workload?                          48 (42.11)    60 (52.63)   6 (5.26)
  Do you feel that proper training should be provided to the HCPs for ADR reporting?   99 (86.84)    14 (12.28)   1 (0.87)
  Do you feel that confidentiality should be maintained while ADR reporting?           83 (72.81)    24 (21.05)   7 (6.14)
  Do you worry about legal problems while you think of ADR reporting                   60 (52.63)    39 (34.21)   15 (13.16)
  Do you feel that ADRs should be reported spontaneously at a regular base?            88 (77.20)    16 (14.04)   10 (8.77)
  Be sure that ADRs are related to the drug before reporting                           87 (76.32)    18 (15.79)   9 (7.89)

###### 

ADR reporting practices of HCPs in selected public hospitals, Northeast Ethiopia, May 2019.

  Questions                                                                 Category   Frequency   Percentage
  ------------------------------------------------------------------------- ---------- ----------- ------------
  Have you encountered patients with ADR in the last 12 months?             Yes        34          29.82
  No                                                                        80         70.18       
                                                                                                   
  How many patients with ADR have you encountered?                          One        11          9.65
  Two                                                                       8          7.02        
  Three                                                                     3          2.63        
  Four                                                                      6          5.26        
  Above four                                                                6          5.26        
                                                                                                   
  Have you recorded the ADR you encountered on patients clinical record?    Yes        24          70.59
  No                                                                        10         29.41       
                                                                                                   
  Have you reported ADRs?                                                   Yes        17          50
  No                                                                        17         50          
                                                                                                   
  If reported, to where did you report that reaction?                       Hospital   8           47.06
  MOH                                                                       2          11.76       
  EFDA                                                                      5          29.41       
  Pharmaceutical company                                                    1          5.88        
  Pharmacy department                                                       8          47.06       
                                                                                                   
  Did you have ADR reporting forms?                                         Yes        29          25.44
  No                                                                        85         74.56       
                                                                                                   
  How often did you advice patients on possible adverse effects of drugs?   Always     48          42.11
  Usually                                                                   22         19.30       
  Sometimes                                                                 38         33.33       
  Never                                                                     6          5.26        

###### 

Perceived reasons for not reporting ADRs among HCPs in selected public hospitals, Northeast Ethiopia, May 2019 (*N* = 114).

  Reasons                                                 Frequency (%)                                          
  ------------------------------------------------------- --------------- ------------ ------------ ------------ ------------
  Concern that the report may be wrong                    46 (40.35)      41(35.96)    11 (9.65)    16 (14.04)   0
  Not knowing how to fill and report ADR                  22 (19.30)      35 (30.70)   12 (10.53)   37 (32.46)   8 (7.02)
  Uncertain of causal association between drug and ADR    21 (18.42)      40 (35.09)   12 (10.53)   38 (33.33)   3 (2.63)
  Lack of time to fill report form                        28 (24.56)      50 (43.86)   11 (9.65)    19 (16.67)   6 (5.26)
  Reporting does not influence the t/t scheme             30 (26.32)      46 (40.35)   10 (8.77)    23 (20.18)   5 (4.39)
  Forgetfulness                                           24 (21.05)      32 (28.07)   19 (16.67)   36 (31.58)   3 (2.63)
  Lack of feedback                                        11 (9.65)       22 (19.30)   14 (12.28)   57 (50)      10 (8.77)
  Fear of legal liability by reporting ADR                21 (18.42)      38 (33.33)   17 (14.91)   37 (32.46)   1 (0.88)
  Concern that a report will generate an extra work       29 (25.44)      42 (36.84)   14 (12.28)   23 (20.18)   6 (5.26)
  Belief that only safe drugs are marketed                39 (34.21)      41 (35.96)   11 (9.65)    20 (17.54)   3 (2.63)
  Thinking that one report does not make any difference   34 (29.82)      41 (35.96)   11 (9.65)    24 (21.05)   4 (3.51)
  Thinking that you may have caused a patient harm        28 (24.56)      51 (44.74)   8 (7.02)     23 (20.18)   4 (3.51)
  My report is not needed/necessary                       38 (33.33)      52 (45.61)   11 (9.65)    11 (9.65)    2 (1.75)
  Insufficient clinical knowledge                         22 (19.30)      35 (30.70)   17 (14.91)   38 (33.33)   2 (1.75)
  Reporting forms are not available when needed           15 (13.16)      30 (26.32)   16 (14.04)   40 (35.09)   13 (11.40)
  Thinking that ADR reporting is not a duty               37 (32.46)      47 (41.23)   4 (3.51)     22 (19.30)   4 (3.51)
  Not knowing where to report                             18 (15.79)      30 (26.32)   13 (11.40)   42 (36.84)   11 (9.65)
  Other colleagues are not reporting ADR cases            19 (16.67)      30 (26.32)   22 (19.30)   39 (34.21)   4 (3.51)

1^a^ = strongly disagree; 2^b^ = disagree; 3^c^ = neutral; 4^d^ = agree; 5^e^ = strongly agree.

###### 

Multivariate analysis of factors associated with knowledge of HCPs in selected public hospitals, Northeast Ethiopia, May 2019.

  Variables                     Knowledge   COR with 95% CI   AOR with 95% CI                
  ----------------------------- ----------- ----------------- ------------------------------ ------------------------------
  *Age (years)*                                                                               
  \<25                          8           17                1                              1
  25--34                        20          61                0.697 \[0.261--1.857\]          
  ≥35                           0           8                 0.000                          0.000
                                                                                             
  *Sex*                                                                                       
  Male                          20          52                1.635 \[0.647--4.130\]          
  Female                        8           34                1                              1
                                                                                             
  *Profession*                                                                                
  Physician                     5           21                0.099 \[0.024--0.414\]^*∗*^    0.140 \[0.030--0.641\]^*∗*^
  Nurse                         6           43                0.058 \[0.015--0.224\]^*∗∗*^   0.069 \[0.018--0.275\]^*∗∗*^
  Health officer                2           10                0.083 \[0.013--0.526\]^*∗*^    0.100 \[0.015--0.647\]^*∗*^
  Midwifery                     3           7                 0.179 \[0.032--0.985\]^*∗*^    0.230 \[0.040--1.336\]
  Pharmacy                      12          5                 1                              1
                                                                                             
  *Level of education*                                                                        
  Diploma                       7           13                1.077 \[0.156--7.420\]          
  BSc                           19          69                0.551 \[0.094--3.329\]          
  MSc/MPH                       2           4                 1                              1
                                                                                             
  *Experience*                                                                                
  \<3 years                     16          39                1.607 \[0.680--3.799\]          
  ≥3 years                      12          47                1                               
                                                                                             
  *Training on ADR reporting*                                                                 
  Not trained                   19          76                0.278 \[0.099--0.779\]         0.451 \[0.124--1.637\]
  Trained                       9           10                1                              1
                                                                                             
  *Hospital*                                                                                  
  Primary                       16          41                1.463 \[0.619--3.458\]          
  General                       12          45                1                               

^*∗*^ *p* \< 0.05 and ^*∗∗*^*p* \< 0.001 (statistically significant).

[^1]: Academic Editor: Janet Sultana
